Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Clinical Research in Southampton
Southampton Children's Hospital
A
A
A
Text only
| Accessibility | Privacy and cookies
"Helpful, informative, polite and friendly staff put my mind at ease"
Patient feedback
Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us
You are here:
Home
>
Search results
Search
Browse site A to Z
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Search results
Go To Advanced Search
Search
You could also try:
family member (384)
,
relative (245)
Sunitinib v1
Description
Chemotherapy Protocol SARCOMA Gastro-Intestinal Stromal Tumour (GIST) Regimen Sunitinib GIST-Sunitinib Indication Sunitinib is recommended as
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Sunitinib-v1.pdf
Regorafenib
Description
Chemotherapy Protocol Gastro-Intestinal Stromal Tumour Regorafenib Regimen • GIST – Regorafenib Indication • Regorafenib is recommended for histologic
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Regorafenib.pdf
Irinotecan-Temozolomide
Description
Chemotherapy Protocol Sarcoma IRINOTECAN - TEMOZOLOMIDE Regimen • Sarcoma – Irinotecan-Temozolomide Indication • Recurrent or progressive Ew
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Irinotecan-Temozolomide.pdf
Cyclophosphamide-Dactinomycin-Vincristine (VAC) v1
Description
Chemotherapy Protocol SARCOMA CYCLOPHOSPHAMIDE-DACTINOMYCIN-VINCRISTINE (VAC) Regimen Sarcoma-Cyclophosphamide-Dactinomycin-Vincristine
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Cyclophosphamide-Dactinomycin-Vincristine-VAC-v1.pdf
Sorafenib version 1.1
Description
Chemotherapy Protocol LIVER SORAFENIB This protocol may require funding Regimen Hepatocellular carcinoma-Sorafenib Indication Hepatocellu
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Sorafenib-version-1.1.pdf
Regorafenib
Description
Chemotherapy Protocol Hepatocellular Cancer Regorafenib Regimen • Hepatocellular – Regorafenib Indication • Regorafenib is recommended as an option fo
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Regorafenib.pdf
Ponatinib
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Ponatinib All licensed indications are not funded therefore an application for funding is requir
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Ponatinib.pdf
NilotinibChronic
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (chronic phase) Regimen • CML – Nilotinib (chronic phase) Indication • As an opti
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibChronic.pdf
NilotinibAccelerated
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (accelerated phase) Regimen • CML – Nilotinib (accelerated phase) Indication • Ni
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibAccelerated.pdf
ImatinibChronic
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (chronic phase) • CML – Imatinib (chronic phase) Indication • As the preferr
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibChronic.pdf
161
to
170
of
312
Previous
…
15
16
17
18
19
…
Next
Site policies
Report a problem with this page
Privacy and cookies
Site map
Translation
Last updated: 14 September 2019
Contact details
University Hospital Southampton NHS Foundation Trust
Tremona Road
Southampton
Hampshire
SO16 6YD
Telephone: 023 8077 7222
Useful links
Home
Getting here
What to do in an emergency
Research
Working here
Education
© 2014 University Hospital Southampton NHS Foundation Trust
Browser does not support script.
Browser does not support script.